Upload Avatar (500 x 500)
Baorui Liu
baoruiliu07@163.com
English, Chinese
Jiangsu
Nanjing University
Medical School
  • Postdoctoral: MD Anderson Cancer Center
  • Vice President of Nanjing University Medical School Affiliated Drum Tower Hospital
  • Director of the Oncology Center
  • Director of the Clinical Oncology Research Institute of Nanjing University
  • Recipient of the China Physician Award
  • Advanced Individual in the National Medical and Health System
  • Expert with Outstanding Contributions in Jiangsu Province
  • 2019: First Prize of Jiangsu Science and Technology Award
  • 2016: Second Prize of Ministry of Education Science and Technology Progress Award
  • 2015: Second Prize of Jiangsu Science and Technology Award
  • 2012: Second Prize of Jiangsu Science and Technology Award
  • 2008: Third Prize of Jiangsu Science and Technology Progress Award
  • 2011: Second Prize of Chinese Medical Science and Technology Award
  • 2015: Third Prize of Chinese Medical Science and Technology Award
  • 2012: Second Prize of China Anti-Cancer Association Science and Technology Award
  • 2010: Second Prize of China Anti-Cancer Association Science and Technology Award
  • 2019: First Prize of Jiangsu Medical Science and Technology Award
  • 2015: Second Prize of Jiangsu Medical Science and Technology Award
  • 2011: Second Prize of Jiangsu Medical Science and Technology Award
  • 2008: Second Prize of Nanjing Science and Technology Progress Award
  • 2010: Third Prize of Jiangsu Traditional Chinese Medicine Science and Technology Award
Personalized Drug Therapy for Digestive System Tumors
Personalized Targeted Immunotherapy
  • Nanotechnology-based CAR-T strategies for improving efficacy and safety of tumor immunotherapy, Baorui Liu, 2021
  • Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors, Baorui Liu, 2019
  • iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer, Baorui Liu, 2019
  • Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives, Baorui Liu, 2020
  • Personalized cancer neoantigen vaccines come of age, Baorui Liu, 2018
  • CRISPR-Cas9 mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer, Baorui Liu, 2017
Personalized Drug Therapy Digestive System Tumors Targeted Immunotherapy Cancer Treatment Oncology Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.